A board-certified gynecologic oncologist, Ama Buskwofie, M.D., provides comprehensive care for patients with gynecologic cancers, with advanced expertise in minimally invasive, open, and complex oncologic surgery. Dr. Buskwofie is a dedicated surgical educator, actively mentoring medical students and residents with a hands-on, thoughtful approach to clinical training.
Her academic work includes numerous peer-reviewed publications and ongoing research focused on surgical innovation and health equity in cancer care. A passionate advocate for eliminating health disparities, Dr. Buskwofie’s clinical and scholarly efforts center on advancing equitable access to high-quality care for underserved and marginalized communities. She is widely respected for her surgical skills, academic leadership, and unwavering commitment to patient-centered, inclusive care.
Education
- Fellowship, Gynecologic Oncology, New York-Presbyterian Hospital/Columbia University Irving Medical Center & Weill Cornell Medicine
- Residency, Obstetrics and Gynecology, Harvard University - Brigham and Women's Hospital & Massachusetts General Hospital
- M.D., Duke University School of Medicine
- B.S., Biology, Colorado State University
Areas of Expertise
- Gynecologic Oncology
- Minimally Invasive and Robotic Gynecologic Surgery
Research
Dr. Buskwofie's research interests center on advancing care for patients with gynecologic malignancies through a multifaceted approach that includes improving surgical outcomes, addressing health disparities, and enhancing surgical education. She is particularly focused on exploring systemic factors contributing to inequities in cancer care, with the goal of developing targeted interventions that improve access and outcomes for underserved populations. Additionally, Dr. Buskwofie is dedicated to the education and mentorship of medical students and residents, with an emphasis on innovative teaching strategies that support surgical proficiency and health equity awareness.
Publications
- Pradhan T, Zhang H, Kadesh A, et. al. "PROJECT PREVENT: a randomized controlled trial of preoperative vaginal metronidazole to decrease patient issues and infections after hysterectomy." BMJ surgery, interventions, & health technologies, 6(1), (2024) e000241. doi: 10.1136/bmjsit-2023-000241
- Buskwofie A, David-West G, Clare CA, et. al. "A Review of Cervical Cancer: Incidence and Disparities." Journal of the National Medical Association, 112(2), (2020) 229-232. doi: 10.1016/j.jnma.2020.03.002
Memberships and Affiliations
- Society of Gynecology Oncology
